August 16, 2006
The common shares of Biosign Technologies Inc. have been approved for listing on CNQ. There are approximately 54.6 million common shares outstanding with a public float of approximately 14.9 million shares. Biosign has developed biosignal instrumentation and measurement technology that is easy-to-use and non-invasive while increasing the relevance, availability, and timeliness of health measurements ultimately improving the standard of patient care.
Listing and disclosure documents for Biosign Technologies will be available in the CNQ Issuer Disclosure Hall
Trading Date: Monday, August 21, 2006
CUSIP: 09070P 10 0
Applications are being accepted for Market Makers for "BIOS". If you have any questions or require further information please contact Radhika Joseph at (416) 572-2000 X 2435 or E-mail: email@example.com